JAN 11, 2018 6:12 AM PST

Biomarkers Affected By Alcohol Linked to Survival of Gastric Cancer Patients

WRITTEN BY: Kara Marker

For the first time, scientists have made a connection between specific biomarkers and gastric cancer outcomes.

Immunohistochemical staining of transcription factor IIB-related factor 1 (BRF1) in gastric cancer. Credit: The American Journal of Pathology

Alcohol consumption is a known risk factor for gastric cancer, partly because it interacts with specific proteins, which ultimately influences how a person with gastric cancer will respond to a type of chemotherapy, platinum-based adjuvant chemotherapy.

One protein, transcription factor IIB-related factor 1 (BRF1), a “key microRNA-processing modulator, has the attention of researchers in a new American Journal of Pathology study. In the past, both alcohol consumption and BRF1 have also been linked to breast and liver cancer.

Additionally, researchers are investigating the role of BRCA1/2, a gene linked to increases in a person’s risk of breast cancer, and myeloperoxidase (MPO), an enzyme linked to risk of heart attack, which are apparently more likely to occur in people with gastric cancer who do not stop drinking alcohol.

“We found that DNA repair-related markers, BRF1, BRCA1/2, and MPO, have good prognostic value in gastric cancer patients with or without harmful alcohol consumption habits,” explained Hua Wang, MD, PhD, and co-senior author Kangsheng Gu, MD, PhD. “Moreover, these proteins are also associated with how effective platinum-based adjuvant chemotherapy will be for gastric cancer patients.”

Wang, Gu, and the other researchers conducted a study with a tissue analysis from 77 patients who had previously received surgery for primary gastric adenocarcinoma, inside and outside the tumor area. Some patients underwent radical surgery (66) while others received platinum-based adjuvant chemotherapy (57). An overwhelming majority (94 percent) experienced disease recurrence within 18 months.

The results showed that BRF1, BRCA1/2, and MPO were effective at predicting which patients would benefit the most from platinum-based adjuvant chemotherapy. They also found that alcohol only continued to make things worse for gastric cancer patients.

But how exactly do these proteins interact with alcohol and contribute toward cancer growth?

"Until now, there have been no good markers to indicate alcohol consumption in gastric cancer tissue," Wang said. "Future larger clinical trials are planned to explore the prognostic utility of these biomarkers in gastric and other cancers in patients who consume hazardous quantities of alcohol."

The present study was published in the American Journal of Pathology.

Sources: Cleveland Clinic, Elsevier

About the Author
  • I am a scientific journalist and enthusiast, especially in the realm of biomedicine. I am passionate about conveying the truth in scientific phenomena and subsequently improving health and public awareness. Sometimes scientific research needs a translator to effectively communicate the scientific jargon present in significant findings. I plan to be that translating communicator, and I hope to decrease the spread of misrepresented scientific phenomena! Check out my science blog: ScienceKara.com.
You May Also Like
MAY 21, 2020
Clinical & Molecular DX
Fidget Spinner Diagnoses Infections
MAY 21, 2020
Fidget Spinner Diagnoses Infections
The fidget spinner toy craze took the world by storm — a small, boomerang-shaped gadget that rotates hypnotically ...
JUL 10, 2020
Cancer
Researching New RNA Biomarkers for Liver Cancer
JUL 10, 2020
Researching New RNA Biomarkers for Liver Cancer
The most important part of cancer treatment is the first step, diagnosis. Many cancers can lie dormant for years, reachi ...
AUG 01, 2020
Cardiology
Identifying Biomarkers for the Diagnosis of Diabetic Cardiomyopathy
AUG 01, 2020
Identifying Biomarkers for the Diagnosis of Diabetic Cardiomyopathy
Type 2 diabetes affects millions around the world.  By itself, it prevents your body from properly using sugars fro ...
AUG 03, 2020
Cancer
Improving Diagnostics in Breast Cancer
AUG 03, 2020
Improving Diagnostics in Breast Cancer
Diagnostics is one of the essential tools in a physician’s toolkit. A good diagnostic test can identify whether a ...
AUG 20, 2020
Clinical & Molecular DX
Machines Learn the Difference Between Autism and Schizophrenia
AUG 20, 2020
Machines Learn the Difference Between Autism and Schizophrenia
 
SEP 12, 2020
Cardiology
Is Hyperuricemia an Indicator of Aortic Disease?
SEP 12, 2020
Is Hyperuricemia an Indicator of Aortic Disease?
Living in a culture of excess can have its benefits, but also its drawbacks. Diabetes is a common disease that is gettin ...
Loading Comments...